Expanding Access to Methadone in Jails and Prisons

Description

Increasing the use of medications for opioid use disorder for incarcerated people is a key intervention to prevent overdose deaths and reduce recidivism. This event, presented by the Bloomberg School of Public Health's Center for Mental Health & Addiction Policy in partnership with the White House Office of National Drug Control Policy, will focus on opportunities to expand access to methadone in correctional facilities, including recent developments with the 2024 Substance Abuse & Mental Health Services Administration (SAMHSA) final rule on the use of methadone. It will feature federal policymakers discussing recent federal initiatives to increase access to treatment as well as state and local leaders and practitioners.

This is a hybrid event; to attend virtually, please select Virtual Attendee and a Zoom link will be sent to you prior to the event.

Featured speakers include:

• Rahul Gupta, director, White House Office of National Drug Control Policy
• Brendan Saloner, Bloomberg professor of American health, Johns Hopkins Bloomberg School of Public Health
• Yngvild Olsen, director, Center for Substance Abuse Treatment, SAMHSA
• Matthew Strait, deputy assistant administrator, Office of Diversion Control Regulatory, Drug Enforcement Administration
• Sara Whaley, senior practice associate, Johns Hopkins Bloomberg School of Public Health
• Catherine Smith, director of addiction medicine, Washington State Department of Corrections